news Cilcare appoints Patricia Machado as Early Drug Development & Pipeline Director Learn More > 30 9月 2024 Cilcare wins prestigious Hearing Technology Innovator Award for CIL001 Learn More > 25 9月 2024 Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects Learn More > 27 6月 2024 Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment Learn More > 6 6月 2024 Cilcare appoints Naimi Missoum as Chief Medical Officer Learn More > 23 5月 2024 Cilcare-CBSET’s review article on ototoxicity published in Frontiers in Molecular Neuroscience ! Learn More > 21 5月 2024 Cilcare featured in NewScientist ! Learn More > 30 4月 2024 Cilcare presenting at the 4th annual Future of Hearing Healthcare conference ! Learn More > 20 4月 2024 Cilcare expands its collaboration network to accelerate revolutionary treatment for cochlear synaptopathy with new clinical trial and biomarker innovation Learn More > 18 4月 2024 « Previous ページ1 ページ2 ページ3 ページ4 … ページ26 Next »
Cilcare appoints Patricia Machado as Early Drug Development & Pipeline Director Learn More > 30 9月 2024
Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects Learn More > 27 6月 2024
Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment Learn More > 6 6月 2024
Cilcare-CBSET’s review article on ototoxicity published in Frontiers in Molecular Neuroscience ! Learn More > 21 5月 2024
Cilcare presenting at the 4th annual Future of Hearing Healthcare conference ! Learn More > 20 4月 2024
Cilcare expands its collaboration network to accelerate revolutionary treatment for cochlear synaptopathy with new clinical trial and biomarker innovation Learn More > 18 4月 2024
